Market Place
Sourcing Support
The first big hurdle on the Celgene CVR arrives today. Can BMY`s clear a low bar
25 Mar 2020 //
ENDPTS
Big Pharma drove 2019 dealmaking, but in 2020, count biotech in
13 Jan 2020 //
FIERCE PHARMA
Gilead takes an $820M hit after axing a Kite CAR-T
04 Feb 2019 //
ENDPTS
JPM 2019: Lilly buys Loxo, Pfizer’s biosimilar bundle and $22 coffee
22 Jan 2019 //
BIOPROCESS INTL
Celgene strikes Obsidian deal to boost CAR-T options
19 Jan 2019 //
FIERCE BIOTECH
Obsidian Therapeutics Announces Strategic Collaboration with Celgene
18 Jan 2019 //
BIOSPACE
Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene
18 Jan 2019 //
BIOSPACE
Forma axes discovery biology team as part of a broader reorganization
18 Jan 2019 //
ENDPTS
BMS Buyout Not Stopping Celgene from Collaborating with Kyn, Obsidian
18 Jan 2019 //
GEN ENG NEWS
Dragonfly preps clinical takeoff, inking a collaboration pact with MD Anderson
18 Jan 2019 //
ENDPTS
A Planned Spinoff Of Cancer Vaccines At Generex
14 Jan 2019 //
SEEKING ALPHA
M&A, IPOs and VC raises: Biotech, medtech execs look to 2019
12 Jan 2019 //
FIERCE BIOTECH
Bluebird endorses plan for installment-based payments for costly gene therapy
10 Jan 2019 //
ENDPTS
IPO bonanza as biotechs get in while the iron’s hot
09 Jan 2019 //
FIERCE BIOTECH
The 20 Hottest Pipeline Drugs to Watch in 2019
03 Jan 2019 //
BIOSPACE
5 Biopharma Trends to Watch in 2019
01 Jan 2019 //
GEN
A new analysis spotlights the top 20 drugs in the late-stage pipeline
14 Dec 2018 //
ENDPTS
Dragonfly Announces Celgene In-license First Two TriNKET™ I-o Drug Candidates
13 Dec 2018 //
PR NEWSWIRE
Targeting CD47? UCLA joins bandwagon, with gel to stem tumors from resurfacing
11 Dec 2018 //
ENDPTS
Celgene expands Dragonfly NK cells pact to the tune of $50M
14 Nov 2018 //
FIERCE BIOTECH
Acceleron, Celgene reveal new clinical trial data on their blood disease drug
01 Nov 2018 //
STAT NEWS
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
20 Sep 2018 //
FORBES
Venter to leave Human Longevity as turnover at the top continues
30 May 2018 //
FIERCE BIOTECH
The Multiple Myeloma Research & Partners Announce To Raise Funds Cancer Research
02 May 2018 //
BUSINESSWIRE
Initial Treatment of People With a Type of Advanced Squamous Lung Cancer
20 Mar 2018 //
GENE.COM
Celgene’s MS drug rejected by FDA due to insufficient data
01 Mar 2018 //
PHARMACEUTICAL JOURNAL
5 Top Biotech Stocks That Look Vulnerable in 2018
09 Jan 2018 //
BIOSACE
World`s Top 5 Best-Selling Drugs in 2017
18 Dec 2017 //
BIOSPACE
Cancer Research Technology links with Celgene
15 Dec 2017 //
PHARMA TIMES
Oral OTEZLA demonstrated significant improvement versus Placebo in trial
14 Mar 2017 //
BIOSPECTRUM
Compound ozanimod shows positive results in late-stage clinical trial
22 Feb 2017 //
SCIENCE DAILY
Celgene partners to develop ResearchKit app for observational study
18 Oct 2016 //
FIERCE BIOTECH
4 Cheap Biotech Stocks Ready to Fly
16 Aug 2016 //
BIOSPACE
What Are Analysts Saying About Q2 at Biotech`s Big 4? Amgen, Biogen, Celgen
28 Jul 2016 //
FORBES
New myeloma meds work better than the old, but they`re far too expensive: Report
12 Apr 2016 //
FIERCE PHARMA
Harnessing The Immune System To Fight Cancer: `Now We Can Offer Hope`
04 Dec 2015 //
FORBES
No real rationale for rising cancer drug prices, JAMA researchers conclude
08 Apr 2015 //
FIERCE PHARMA
